Status:
COMPLETED
HIV-1 Resistance at Screening for HIV Prevention Studies
Lead Sponsor:
Microbicide Trials Network
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV
Eligibility:
FEMALE
18-40 years
Brief Summary
MTN-009 is a multi-site, cross-sectional study that will provide an estimate of the prevalence of ARV resistance in the population of women who present to study sites to be pre-screened or screened fo...
Detailed Description
MTN-009 is a multi-site, cross-sectional study that will provide an estimate of the prevalence of ARV resistance in the population of women who present to study sites to be pre-screened or screened fo...
Eligibility Criteria
Inclusion
- Present to an MTN-009 study site to pre-screen or screen for an HIV prevention trial
- Age 18-40 years, verified per site standard operating procedures (SOP)
- Able and willing to provide written informed consent for participation in MTN-009
- Able and willing to provide adequate locator information, as defined in site SOPs
Exclusion
- Any condition that, in the investigator's opinion, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achievement of the study objectives
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
1074 Patients enrolled
Trial Details
Trial ID
NCT01204814
Start Date
August 1 2010
End Date
July 1 2011
Last Update
June 21 2021
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
South African Medical Research Council, HIV Prevention Research Unit
Durban, KwaZulu-Natal, South Africa, 3630
2
South African Medical Research Council, Botha's Hill
Durban, KwaZulu-Natal, South Africa
3
South African Medical Research Council, Isipingo
Durban, KwaZulu-Natal, South Africa
4
South African Medical Research Council, RK Khan (Chatsworth)
Durban, KwaZulu-Natal, South Africa